Children’s Hospital Los Angeles investigator shows that non-caloric sweetener stevia decreases signs of fatty liver disease in a pre-clinical model.
Source: Non-caloric sweetener reduces signs of fatty liver disease in preclinical research study
My Personal Biomedical Research Feed – Ralph Turchiano, CEO Alchepharma
Children’s Hospital Los Angeles investigator shows that non-caloric sweetener stevia decreases signs of fatty liver disease in a pre-clinical model.
Source: Non-caloric sweetener reduces signs of fatty liver disease in preclinical research study
Subscribe now to keep reading and get access to the full archive.